Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 9 | 2025 | 50 | 5.150 |
Why?
|
| Cerebral Hemorrhage | 6 | 2025 | 7 | 2.970 |
Why?
|
| Status Epilepticus | 7 | 2024 | 8 | 2.820 |
Why?
|
| Consciousness Disorders | 6 | 2025 | 10 | 2.680 |
Why?
|
| Stroke | 8 | 2025 | 48 | 2.680 |
Why?
|
| Electroencephalography | 12 | 2024 | 73 | 2.560 |
Why?
|
| Withholding Treatment | 3 | 2025 | 10 | 2.510 |
Why?
|
| Coma | 5 | 2024 | 8 | 2.510 |
Why?
|
| Brain Injuries | 4 | 2025 | 25 | 2.510 |
Why?
|
| Recovery of Function | 4 | 2025 | 18 | 2.380 |
Why?
|
| Humans | 47 | 2025 | 4936 | 2.070 |
Why?
|
| Aged | 22 | 2025 | 703 | 2.010 |
Why?
|
| Registries | 8 | 2025 | 22 | 1.860 |
Why?
|
| Life Support Care | 2 | 2025 | 4 | 1.830 |
Why?
|
| Middle Aged | 22 | 2025 | 967 | 1.800 |
Why?
|
| Female | 27 | 2025 | 2523 | 1.570 |
Why?
|
| Male | 23 | 2025 | 2491 | 1.400 |
Why?
|
| Hospital Mortality | 5 | 2025 | 11 | 1.370 |
Why?
|
| Machine Learning | 3 | 2025 | 35 | 1.280 |
Why?
|
| Critical Care | 4 | 2022 | 12 | 1.210 |
Why?
|
| Severity of Illness Index | 4 | 2025 | 51 | 1.190 |
Why?
|
| Seizures | 4 | 2022 | 9 | 1.100 |
Why?
|
| Brain Ischemia | 3 | 2023 | 6 | 1.080 |
Why?
|
| Hematoma | 1 | 2025 | 1 | 0.940 |
Why?
|
| Brain | 5 | 2024 | 195 | 0.930 |
Why?
|
| Pain Measurement | 1 | 2025 | 18 | 0.920 |
Why?
|
| Pain | 1 | 2025 | 41 | 0.890 |
Why?
|
| Prognosis | 5 | 2025 | 60 | 0.870 |
Why?
|
| Intensive Care Units | 6 | 2025 | 17 | 0.850 |
Why?
|
| Hospitalization | 1 | 2024 | 38 | 0.850 |
Why?
|
| Consciousness | 5 | 2024 | 10 | 0.840 |
Why?
|
| Aged, 80 and over | 10 | 2025 | 262 | 0.800 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 137 | 0.800 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 55 | 0.790 |
Why?
|
| Adult | 11 | 2025 | 1567 | 0.790 |
Why?
|
| Retrospective Studies | 10 | 2025 | 341 | 0.730 |
Why?
|
| Glasgow Coma Scale | 4 | 2025 | 5 | 0.700 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 62 | 0.690 |
Why?
|
| Biomarkers | 4 | 2025 | 81 | 0.660 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 9 | 0.650 |
Why?
|
| Time-to-Treatment | 3 | 2025 | 5 | 0.640 |
Why?
|
| Amantadine | 1 | 2020 | 1 | 0.640 |
Why?
|
| Dopamine Agents | 1 | 2020 | 3 | 0.640 |
Why?
|
| Florida | 8 | 2025 | 12 | 0.590 |
Why?
|
| Prospective Studies | 5 | 2025 | 111 | 0.550 |
Why?
|
| Patient Discharge | 3 | 2025 | 18 | 0.420 |
Why?
|
| Heart Arrest | 2 | 2024 | 4 | 0.380 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2023 | 4 | 0.360 |
Why?
|
| Thrombolytic Therapy | 3 | 2025 | 3 | 0.330 |
Why?
|
| Treatment Outcome | 6 | 2025 | 177 | 0.300 |
Why?
|
| Thrombectomy | 2 | 2025 | 3 | 0.280 |
Why?
|
| Endovascular Procedures | 2 | 2025 | 2 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2025 | 26 | 0.270 |
Why?
|
| Antihypertensive Agents | 2 | 2025 | 17 | 0.260 |
Why?
|
| Clinical Competence | 2 | 2023 | 12 | 0.240 |
Why?
|
| Hypertension | 2 | 2025 | 58 | 0.240 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 269 | 0.240 |
Why?
|
| Chemokines | 1 | 2025 | 4 | 0.240 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2025 | 2 | 0.230 |
Why?
|
| Glasgow Outcome Scale | 1 | 2025 | 3 | 0.230 |
Why?
|
| Caspase 1 | 1 | 2025 | 11 | 0.230 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2025 | 2 | 0.230 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 1 | 2025 | 2 | 0.230 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2025 | 4 | 0.230 |
Why?
|
| Cytokines | 1 | 2025 | 37 | 0.230 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2025 | 10 | 0.230 |
Why?
|
| Patient Readmission | 1 | 2025 | 8 | 0.230 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 30 | 0.230 |
Why?
|
| Data Collection | 2 | 2023 | 14 | 0.230 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2025 | 1 | 0.230 |
Why?
|
| Certification | 2 | 2023 | 4 | 0.220 |
Why?
|
| Brain Death | 1 | 2025 | 3 | 0.220 |
Why?
|
| Cerebrovascular Circulation | 1 | 2025 | 6 | 0.220 |
Why?
|
| Inflammasomes | 1 | 2025 | 40 | 0.220 |
Why?
|
| Length of Stay | 2 | 2021 | 7 | 0.220 |
Why?
|
| Blood Pressure | 2 | 2023 | 40 | 0.220 |
Why?
|
| Neurophysiological Monitoring | 2 | 2021 | 2 | 0.210 |
Why?
|
| Ketamine | 1 | 2024 | 3 | 0.210 |
Why?
|
| Guideline Adherence | 1 | 2023 | 3 | 0.200 |
Why?
|
| Young Adult | 2 | 2025 | 787 | 0.200 |
Why?
|
| Cluster Analysis | 1 | 2023 | 22 | 0.200 |
Why?
|
| Common Data Elements | 1 | 2023 | 2 | 0.200 |
Why?
|
| Biomedical Research | 1 | 2023 | 10 | 0.200 |
Why?
|
| Paresthesia | 1 | 2023 | 1 | 0.200 |
Why?
|
| Electroconvulsive Therapy | 1 | 2023 | 1 | 0.200 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2023 | 1 | 0.200 |
Why?
|
| Physical Examination | 1 | 2023 | 6 | 0.200 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2023 | 47 | 0.200 |
Why?
|
| Delirium | 1 | 2023 | 7 | 0.190 |
Why?
|
| Punctures | 1 | 2023 | 2 | 0.190 |
Why?
|
| Aftercare | 1 | 2023 | 6 | 0.190 |
Why?
|
| Survivors | 1 | 2023 | 14 | 0.190 |
Why?
|
| Vision Disorders | 1 | 2023 | 43 | 0.190 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2022 | 1 | 0.190 |
Why?
|
| Risk Factors | 4 | 2025 | 159 | 0.190 |
Why?
|
| Resuscitation Orders | 1 | 2021 | 1 | 0.180 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2021 | 1 | 0.180 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 1 | 0.170 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2021 | 1 | 0.170 |
Why?
|
| Prone Position | 1 | 2021 | 1 | 0.170 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2021 | 1 | 0.170 |
Why?
|
| Epilepsy | 1 | 2021 | 11 | 0.170 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 6 | 0.170 |
Why?
|
| Physicians | 1 | 2021 | 17 | 0.170 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 4 | 0.160 |
Why?
|
| Precision Medicine | 1 | 2020 | 10 | 0.160 |
Why?
|
| Forecasting | 1 | 2020 | 19 | 0.160 |
Why?
|
| Recurrence | 1 | 2020 | 23 | 0.160 |
Why?
|
| Child | 3 | 2025 | 627 | 0.130 |
Why?
|
| Adolescent | 3 | 2025 | 758 | 0.130 |
Why?
|
| Infant, Newborn | 2 | 2025 | 48 | 0.120 |
Why?
|
| Infant | 2 | 2025 | 78 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2025 | 180 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2025 | 81 | 0.100 |
Why?
|
| Time Factors | 2 | 2024 | 163 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2025 | 2 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2025 | 17 | 0.060 |
Why?
|
| Stroke Rehabilitation | 1 | 2025 | 7 | 0.060 |
Why?
|
| Multimorbidity | 1 | 2025 | 4 | 0.060 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 40 | 0.060 |
Why?
|
| Age Factors | 1 | 2025 | 65 | 0.050 |
Why?
|
| Prevalence | 1 | 2025 | 66 | 0.050 |
Why?
|
| Reference Standards | 1 | 2023 | 12 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 8 | 0.050 |
Why?
|
| Consensus | 1 | 2023 | 12 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2023 | 19 | 0.050 |
Why?
|
| Aspirin | 1 | 2023 | 4 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 17 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2023 | 25 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2023 | 5 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2023 | 24 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2023 | 26 | 0.050 |
Why?
|
| Puerto Rico | 1 | 2023 | 4 | 0.050 |
Why?
|
| Research Design | 1 | 2023 | 29 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2023 | 1 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2023 | 3 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2023 | 115 | 0.050 |
Why?
|
| Minority Groups | 1 | 2023 | 35 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 258 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2021 | 11 | 0.040 |
Why?
|
| Death | 1 | 2021 | 2 | 0.040 |
Why?
|
| Depression | 1 | 2023 | 125 | 0.040 |
Why?
|
| Triage | 1 | 2021 | 1 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2021 | 3 | 0.040 |
Why?
|
| Scalp | 1 | 2021 | 7 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2021 | 1 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 197 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2021 | 4 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 64 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 44 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 126 | 0.040 |
Why?
|